SEPOY.net
No Result
View All Result
Monday, June 16, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

Nicholas by Nicholas
June 19, 2023
in Health
0
CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Centers for Disease Control and Prevention (US-CDC) presented preliminary data showing an increase in meningococcal disease among human immunodeficiency virus (HIV)-infected individuals in the US in 2022. 

READ ALSO

Health care employment rebounds after the pandemic but staffing gaps remain

Rapid generation of functional blood vessels from human stem cells

Study: Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022. Image Credit: NovikovAleksey/Shutterstock.comStudy: Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022. Image Credit: NovikovAleksey/Shutterstock.com

Background

Neisseria meningitides cause meningococcal disease, an illness typically manifesting as meningitis or meningococcemia. Some of the most frequent and shared signs and symptoms of meningitis and meningococcemia include fever, chills, headache, stiff neck, fatigue, and severe pain.

The US Advisory Committee on Immunization Practices (ACIP) recommended the use of a quadrivalent, two-dose series of meningococcal conjugate vaccination (MenACWY) for the HIV-infected population of the country.

Subsequently, in 2016, the US incorporated it into the immunization schedule. Likewise, they recommend its routine use for adolescents and persons at a higher risk for meningococcal disease. 

However, an analysis of administrative claims data undertaken between January 2016 and March 2018 showed that vaccine coverage for MenACWY remained low among HIV-infected individuals, with only 16.3% receiving one or more than one dose of the MenACWY vaccine within two years of diagnosis. 

The Notifiable Diseases Surveillance System (NDSS), with extra epidemiologic data and isolates retrieved through enhanced surveillance, reported all meningococcal disease cases in the US.

They used whole genome sequencing (WGS) to characterize and determine serogroup and molecular typing information from these isolates, and the CDC reviewed this activity per the applicable federal law and policy.

Observations

Based on preliminary data, between 2017 and 2021, five to 15 meningococcal disease cases occurred among HIV-infected people annually, representing 1.5% to 4.3% of all disease cases.

In 2022, this case number surged to 29, representing 9.8% of all cases in HIV-infected people annually; however, these cases might increase further when data reporting is complete.

The CDC found that only one person among all 29 meningococcal disease cases in the HIV-infected population in 2022 had received the MenACWY vaccine, but even his dosage schedule was unknown. The remaining 22 people had not received the MenACWY vaccine, while six had unknown MenACWY vaccination history. 

Furthermore, 15/29 cases occurred in men who have sex with men (MSM) during a large serogroup C outbreak. Compared to the 2017–2021 period, in 2022, even after excluding MSM outbreak-associated cases, the meningococcal disease cases remained higher among HIV-infected people (four to eight vs. 14).

Of the remaining 14 cases unrelated to the outbreak, nine were due to a single N. meningitidis strain identified across three US states with no connections among all identified cases. 

Notably, eight of these nine cases occurred in people of African origin (Black Americans) and seven among MSM. CDC identified it as serogroup Y clonal complex CC174 sequence type ST-1466. The rest five cases had no epidemiologic connections and did not cluster geographically.

Conclusions

The current CDC report highlighted that the MenACWY vaccine coverage among the HIV-infected population of the US was low till 2022.

Thus, meningococcal disease cases increased in this population. The report raises the need to encourage HIV-infected people to be up to date with MenACWY and other vaccinations per ACIP recommendations.

Healthcare providers should help achieve these goals while maintaining a high index of suspicion for meningococcal disease among the HIV-infected U.S. population.

Screening of patients with meningococcal disease for HIV is vital. In fact, the CDC highly recommends screening all people for HIV. 

Tags: FatigueFeverHeadacheHIVImmunizationImmunodeficiencyMeningitisMeningococcal DiseaseMeningococcemiaMortalityNeckPainVaccineVirus

Related Posts

Health care employment rebounds after the pandemic but staffing gaps remain
Health

Health care employment rebounds after the pandemic but staffing gaps remain

June 16, 2025
Rapid generation of functional blood vessels from human stem cells
Health

Rapid generation of functional blood vessels from human stem cells

June 14, 2025
Cardiovascular deaths surge among less educated Americans
Health

Cardiovascular deaths surge among less educated Americans

June 14, 2025
Small antibodies provide broad protection against SARS coronaviruses
Health

Small antibodies provide broad protection against SARS coronaviruses

June 14, 2025
c-Fos exhibits a dual role in memory formation and Alzheimer's disease
Health

c-Fos exhibits a dual role in memory formation and Alzheimer's disease

June 14, 2025
BRCA mutations sharply increase risk of implant-associated lymphoma
Health

BRCA mutations sharply increase risk of implant-associated lymphoma

June 14, 2025
Next Post
Inflation: the markets are too “optimistic” according to Goldman Sachs

Inflation: the markets are too “optimistic” according to Goldman Sachs

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Top ten Gambling establishment Betting Internet sites the real deal Profit the united states 2025
  • Free Online Caillou Play Free Fraise No Download
  • Age of Breakthrough Casino slot games Gamble On the internet 100percent free Today

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net